17th Hong Kong International Wine & Spirits Fair wraps up on a high note with over 8,200 buyers 
The 33rd Hong Kong International Optical Fair attracts some 12,000 buyers 
TSplus Remote Support 4.3: Faster, Smarter, and More User-Friendly Than Ever 
KOCCA’s WelCon Marketplace Expands Global K-Content Collaboration with 2025 Virtual Exchange Event Cara Therapeutics to Announce Fourth Quarter and Full Year 2020 Financial Results on February 25, 2021
STAMFORD, Conn., Feb. 18, 2021 (GLOBE NEWSWIRE) — Cara Therapeutics, Inc. (Nasdaq: CARA), a biopharmaceutical company…
Assertio Holdings, Inc. to Report Fourth Quarter and Full Year 2020 Financial Results After the Close of Markets on Thursday, March 11, 2021
LAKE FOREST, Ill., Feb. 18, 2021 (GLOBE NEWSWIRE) — Assertio Holdings, Inc. (“Assertio” or the…
Bio-Path Holdings, Inc. Announces Closing of $13.0 Million Public Offering of Common Stock
HOUSTON, Feb. 18, 2021 (GLOBE NEWSWIRE) — Bio-Path Holdings, Inc., (Nasdaq:BPTH), a biotechnology company leveraging…
Oyster Point Pharma Reports Fourth Quarter and Full Year 2020 Financial Results and Recent Business Highlights
OC-01 (Varenicline) Nasal Spray New Drug Application (NDA) Submitted to the U.S. Food and Drug…
Voyager Therapeutics to Report Fourth Quarter and Full Year 2020 Financial Results and Participate in Upcoming Investor Conference
CAMBRIDGE, Mass., Feb. 18, 2021 (GLOBE NEWSWIRE) — Voyager Therapeutics, Inc. (NASDAQ: VYGR), a clinical-stage…
Paratek Pharmaceuticals to Present at the 10th Annual SVB Leerink Global Healthcare Conference
BOSTON, Feb. 18, 2021 (GLOBE NEWSWIRE) — Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK), a commercial-stage biopharmaceutical…
Adverum Appoints Christopher J. DeRespino as Chief Business Officer
REDWOOD CITY, Calif., Feb. 18, 2021 (GLOBE NEWSWIRE) — Adverum Biotechnologies, Inc. (Nasdaq: ADVM), a…
Pipeline and capital for growth
Key 2020 events: Jyseleca approved for rheumatoid arthritis (RA) in Europe & Japan Gilead decided…
Constellation Pharmaceuticals to Host Conference Call to Discuss Fourth Quarter 2020 Results
CAMBRIDGE, Mass., Feb. 18, 2021 (GLOBE NEWSWIRE) — Constellation Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company using…
CBD Companies Will Lose Market Share to Delta 8 THC Hemp Products in 2021
Las Vegas, Feb. 18, 2021 (GLOBE NEWSWIRE) — When the mainstream thinks of marijuana, they…
Pfizer and BioNTech Commence Global Clinical Trial to Evaluate COVID-19 Vaccine in Pregnant Women
Phase 2/3 trial will enroll approximately 4,000 healthy pregnant women in the U.S., Canada, Argentina,…
GBS Inc. Enters Sponsored Research Agreement with Johns Hopkins Bloomberg School of Public Health To Accelerate Development of Saliva-Based Diagnostic Tests
NEW YORK, Feb. 18, 2021 (GLOBE NEWSWIRE) — GBS Inc. (Nasdaq: GBS), a life sciences…
Courtney Barton Joins Arcutis as Chief Compliance Officer and Chief of Staff
WESTLAKE VILLAGE, Calif., Feb. 18, 2021 (GLOBE NEWSWIRE) — Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a…
Turning Point Therapeutics to Host Fourth Quarter and Full-Year 2020 Conference Call
SAN DIEGO, Feb. 18, 2021 (GLOBE NEWSWIRE) — Turning Point Therapeutics, Inc. (NASDAQ: TPTX), a…
Pandion Therapeutics to Present at the 10th Annual SVB Leerink Global Healthcare Conference
WATERTOWN, Mass., Feb. 18, 2021 (GLOBE NEWSWIRE) — Pandion Therapeutics, Inc. (Nasdaq: PAND), a clinical-stage…
Alimera Sciences Continues Global Geographic Expansion With Launch of ILUVIEN in Finland for Both Indications
ATLANTA, Feb. 18, 2021 (GLOBE NEWSWIRE) — Alimera Sciences, Inc. (NASDAQ: ALIM) (Alimera), a pharmaceutical…
Ocuphire Initiates Enrollment in VEGA-1 Phase 2 Trial Investigating Nyxol in Presbyopia
Nyxol and Low-Dose (0.4%) Pilocarpine Combination to Target Improvement in Near Vision in a Presbyopic…
Allogene Therapeutics to Report Fourth Quarter and Full Year 2020 Financial Results on February 25, 2021
Conference Call and Webcast Scheduled for 2:00 PM PT/5:00 PM ET SOUTH SAN FRANCISCO, Calif.,…
Albireo to Report Q4 and Year-End 2020 Financial Results on February 25
Conference call and webcast to be held at 10:00 a.m. ET BOSTON, Feb. 18, 2021…
Pliant Therapeutics to Participate in Upcoming Virtual Investor Events
SOUTH SAN FRANCISCO, Calif., Feb. 18, 2021 (GLOBE NEWSWIRE) — Pliant Therapeutics, Inc. (Nasdaq: PLRX),…